Editorial
World J Gastroenterol
31(10):101838.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101838
Abstract (455)
|
Core Tip (526)
|
Full Article (HTML) (1995)
|
Full Article (PDF)-378K (145)
|
Full Article with Cover (PDF)-633K (134)
|
Full Article (XML)-71K (88)
|
Audio-3309K (46)
|
Peer-Review Report-245K (82)
|
Answering Reviewers-157K (90)
|
Received: 09/28/2024
|
Revised: 01/23/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (4518)
|
Similar Articles (160)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Review
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches
World J Gastroenterol
31(10):102289.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102289
Abstract (616)
|
Core Tip (509)
|
Full Article (HTML) (10705)
|
Figures (1-1) (500)
|
Tables (1-3) (478)
|
Full Article (PDF)-4025K (506)
|
Full Article with Cover (PDF)-4275K (236)
|
Full Article (XML)-507K (100)
|
Audio-1047K (33)
|
Peer-Review Report-271K (109)
|
Answering Reviewers-120K (119)
|
Received: 10/13/2024
|
Revised: 11/28/2024
|
Accepted: 01/17/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (16106)
|
Similar Articles (333)
|
Timeline of Article Publication (14)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
World J Gastroenterol
31(10):103454.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103454
Abstract (417)
|
Core Tip (446)
|
Full Article (HTML) (2388)
|
Figures (1-1) (374)
|
Full Article (PDF)-1122K (145)
|
Full Article with Cover (PDF)-1376K (140)
|
Full Article (XML)-113K (89)
|
Audio-412K (19)
|
Peer-Review Report-223K (88)
|
Answering Reviewers-109K (74)
|
Received: 11/20/2024
|
Revised: 12/31/2024
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6055)
|
Similar Articles (1873)
|
Timeline of Article Publication (10)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Control Study
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
World J Gastroenterol
31(10):103716.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103716
Abstract (450)
|
Core Tip (503)
|
Full Article (HTML) (2005)
|
Figures (1-1) (357)
|
Tables (1-6) (354)
|
Full Article (PDF)-876K (132)
|
Full Article with Cover (PDF)-1130K (157)
|
Full Article (XML)-191K (100)
|
Audio-454K (28)
|
Peer-Review Report-229K (83)
|
Answering Reviewers-124K (70)
|
Supplementary Material-657K (87)
|
Received: 11/27/2024
|
Revised: 01/16/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6415)
|
Similar Articles (81)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms
World J Gastroenterol
31(10):100444.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100444
Abstract (476)
|
Core Tip (523)
|
Full Article (HTML) (1804)
|
Figures (1-4) (378)
|
Tables (1-3) (375)
|
Full Article (PDF)-8140K (215)
|
Full Article with Cover (PDF)-8392K (142)
|
Full Article (XML)-121K (91)
|
Audio-885K (42)
|
Peer-Review Report-197K (95)
|
Answering Reviewers-155K (110)
|
Supplementary Material-123K (83)
|
Received: 08/16/2024
|
Revised: 12/11/2024
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7068)
|
Similar Articles (19)
|
Timeline of Article Publication (11)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Gastroenterol
31(10):102393.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102393
Abstract (459)
|
Core Tip (581)
|
Full Article (HTML) (1762)
|
Figures (1-2) (399)
|
Tables (1-3) (372)
|
Full Article (PDF)-3168K (195)
|
Full Article with Cover (PDF)-3422K (159)
|
Full Article (XML)-97K (91)
|
Audio-586K (44)
|
Peer-Review Report-221K (116)
|
Answering Reviewers-311K (86)
|
Supplementary Material-128K (95)
|
Received: 10/16/2024
|
Revised: 01/04/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (6229)
|
Similar Articles (3)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Circular RNA contributes to gastric cancer by targeting Wnt family member 2B as a competing endogenous RNA
World J Gastroenterol
31(10):99583.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.99583
Abstract (435)
|
Core Tip (478)
|
Full Article (HTML) (1433)
|
Figures (1-6) (363)
|
Full Article (PDF)-10367K (153)
|
Full Article with Cover (PDF)-10622K (148)
|
Full Article (XML)-108K (88)
|
Audio-200K (12)
|
Peer-Review Report-203K (87)
|
Answering Reviewers-316K (125)
|
Received: 10/23/2024
|
Revised: 12/26/2024
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (4352)
|
Similar Articles (1274)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Platelet activation relieves liver portal hypertension via the lymphatic system though the classical vascular endothelial growth factor receptor 3 signaling pathway
World J Gastroenterol
31(10):100194.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100194
Abstract (443)
|
Core Tip (437)
|
Full Article (HTML) (1943)
|
Figures (1-8) (432)
|
Full Article (PDF)-42475K (185)
|
Full Article with Cover (PDF)-42729K (173)
|
Full Article (XML)-113K (96)
|
Audio-352K (21)
|
Peer-Review Report-309K (77)
|
Answering Reviewers-116K (79)
|
Supplementary Material-190K (89)
|
Received: 08/09/2024
|
Revised: 12/16/2024
|
Accepted: 01/21/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (5322)
|
Similar Articles (143)
|
Timeline of Article Publication (12)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption
World J Gastroenterol
31(10):101014.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.101014
Abstract (434)
|
Core Tip (489)
|
Full Article (HTML) (1858)
|
Figures (1-6) (359)
|
Tables (1-1) (402)
|
Full Article (PDF)-10815K (176)
|
Full Article with Cover (PDF)-11065K (157)
|
Full Article (XML)-143K (86)
|
Audio-400K (38)
|
Peer-Review Report-253K (78)
|
Answering Reviewers-98K (83)
|
Supplementary Material-270K (91)
|
Received: 09/03/2024
|
Revised: 12/19/2024
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6841)
|
Similar Articles (19)
|
Timeline of Article Publication (5)
|
Authors Evaluation (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells
World J Gastroenterol
31(10):103133.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103133
Abstract (474)
|
Core Tip (503)
|
Full Article (HTML) (1814)
|
Figures (1-7) (421)
|
Full Article (PDF)-9623K (180)
|
Full Article with Cover (PDF)-9876K (142)
|
Full Article (XML)-121K (98)
|
Audio-824K (19)
|
Peer-Review Report-275K (93)
|
Answering Reviewers-363K (104)
|
Supplementary Material-48K (83)
|
Received: 11/10/2024
|
Revised: 01/04/2025
|
Accepted: 02/05/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5318)
|
Similar Articles (1849)
|
Timeline of Article Publication (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
World J Gastroenterol
31(10):100771.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.100771
Abstract (426)
|
Core Tip (469)
|
Full Article (HTML) (1017)
|
Figures (1-1) (385)
|
Tables (1-2) (397)
|
Full Article (PDF)-471K (108)
|
Full Article with Cover (PDF)-728K (82)
|
Full Article (XML)-61K (93)
|
Audio-512K (27)
|
Peer-Review Report-257K (76)
|
Answering Reviewers-156K (80)
|
Received: 08/25/2024
|
Revised: 01/10/2025
|
Accepted: 02/10/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3951)
|
Similar Articles (25)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102580.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102580
Abstract (513)
|
Core Tip (569)
|
Full Article (HTML) (1866)
|
Tables (1-1) (467)
|
Full Article (PDF)-370K (141)
|
Full Article with Cover (PDF)-625K (138)
|
Full Article (XML)-56K (90)
|
Audio-2970K (19)
|
Peer-Review Report-217K (80)
|
Answering Reviewers-149K (83)
|
Received: 10/22/2024
|
Revised: 01/16/2025
|
Accepted: 02/08/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4746)
|
Similar Articles (176)
|
Timeline of Article Publication (3)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):102725.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.102725
Abstract (522)
|
Core Tip (489)
|
Full Article (HTML) (4028)
|
Figures (1-1) (386)
|
Full Article (PDF)-1500K (193)
|
Full Article with Cover (PDF)-1754K (153)
|
Full Article (XML)-97K (88)
|
Audio-476K (26)
|
Peer-Review Report-468K (79)
|
Answering Reviewers-1818K (99)
|
Received: 10/27/2024
|
Revised: 01/16/2025
|
Accepted: 01/23/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (7117)
|
Similar Articles (305)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed
World J Gastroenterol
31(10):103420.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103420
Abstract (424)
|
Core Tip (469)
|
Full Article (HTML) (1958)
|
Figures (1-1) (345)
|
Tables (1-1) (393)
|
Full Article (PDF)-578K (137)
|
Full Article with Cover (PDF)-834K (146)
|
Full Article (XML)-91K (82)
|
Audio-833K (26)
|
Peer-Review Report-243K (80)
|
Answering Reviewers-100K (83)
|
Received: 11/18/2024
|
Revised: 01/31/2025
|
Accepted: 02/12/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5126)
|
Similar Articles (1849)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Gastroenterol
31(10):103973.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.103973
Abstract (463)
|
Core Tip (516)
|
Full Article (HTML) (4529)
|
Full Article (PDF)-406K (327)
|
Full Article with Cover (PDF)-661K (182)
|
Full Article (XML)-95K (100)
|
Audio-989K (41)
|
Peer-Review Report-215K (74)
|
Answering Reviewers-118K (82)
|
Received: 12/05/2024
|
Revised: 01/24/2025
|
Accepted: 02/11/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (7283)
|
Similar Articles (3)
|
Timeline of Article Publication (2)
|
Authors Evaluation (4)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
World J Gastroenterol
31(10):104429.
Published online Mar 14, 2025.
doi: 10.3748/wjg.v31.i10.104429
Abstract (471)
|
Core Tip (415)
|
Full Article (HTML) (1350)
|
Tables (1-1) (366)
|
Full Article (PDF)-366K (136)
|
Full Article with Cover (PDF)-621K (157)
|
Full Article (XML)-45K (87)
|
Audio-1658K (24)
|
Peer-Review Report-175K (69)
|
Answering Reviewers-38K (73)
|
Received: 12/19/2024
|
Revised: 01/13/2025
|
Accepted: 01/24/2025
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4188)
|
Similar Articles (1906)
|
Timeline of Article Publication (4)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
